Eva Van Braeckel

Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

Qian Zhang, Paul Bastard, Zhiyong Liu et al. · Science · 2020 · 2.4K citations · Full text

Life Sciences, Immunology, Infectious Diseases +16

Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial

Harry Heijerman, Edward F. McKone, D.G. Downey et al. · The Lancet · 2019 · 1.4K citations · Full text

Life Sciences, Genetics, Pharmacology +14

Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients

Marta Francesca Di Pasquale, Giovanni Sotgiu, Andrea Gramegna et al. · Clinical Infectious Diseases · 2018 · 256 citations · Full text

Medicine, Immunology, Infectious Diseases +12

The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies

Jérémy Manry, Paul Bastard, Adrian Gervais et al. · Proceedings of the National Academy of Sciences · 2022 · 193 citations · Full text

Life Sciences, Immunology, Infectious Diseases +15

Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study

Stefano Aliberti, Luis Felipe Reyes, Paola Faverio et al. · The Lancet Infectious Diseases · 2016 · 175 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16